In the last week, two scientific papers have made a renewed case against cannabis based on the potential risks to users’ mental health. Rather than dismissing them as more prohibition propaganda, Cannabiz editor-at-large Rhys Cohen analyses the evidence and what it means for industry advocates.

When a scientific paper is published that even hints at the possibility of cannabis having medicinal or socially beneficial effects, people in the industry (such as myself) are quick to celebrate. A lot of the time, the technical content of these publications goes over our heads. I, for one, am not a scientist. But we are happy to take the scientists at their word.

Cannabiz editor-at-large Rhys Cohen

When a paper concludes that some kinds of cannabis use may be risky or harmful, we tend to dismiss it. Our impulse is to disbelieve the findings because they conflict with our established beliefs. You can’t blame pro-cannabis people for being sceptical – we’re only now emerging from decades of literal propaganda, deliberately orchestrated by the most powerful institutions in the world. There’s that old saying: just because you’re paranoid, doesn’t mean they’re not out to get you.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Vel turpis nunc eget lorem dolor sed. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh. Nisl nunc mi ipsum faucibus vitae.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Rhys Cohen

As well as being editor-at-large at Cannabiz, Rhys is the director of Cannabis Consulting Australia, which provides commercial consulting services to various domestic and international cannabis companies....

Join the Conversation

1 Comment

  1. Great review, thank you, Rhys. Separating “harm” from recreational cannabis and medicinal cannabis would, in my view, also provide valuable insight. I suspect the rates of schizophrenia are higher amongst recreational users than medicinal cannabis users but don’t have the data to support that. Gail Wiseman (AMCA)